New combo drug aims to tackle high cholesterol in one daily pill
NCT ID NCT03527069
First seen Jan 05, 2026 · Last updated Jun 22, 2026 · Updated 28 times
Summary
This Phase 3 trial tested a new combination drug called Cipros 10 against the standard statin Crestor in 146 adults with dyslipidemia (high cholesterol and triglycerides). The goal was to see if Cipros 10 could lower triglyceride levels more effectively. Participants took one pill daily, and researchers tracked both lab results and any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Allergisa
Campinas, São Paulo, Brazil
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cipros 10 (a combination drug containing rosuvastatin and other agents)
What this could lead to
If successful, this could offer a new once-daily pill option to help control high triglycerides and cholesterol.
What could go wrong
This is a completed Phase 3 trial, but results are not yet published. The drug may not prove significantly better than existing statins like Crestor, and side effects are possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.